Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Post-Approval (Research/Post Marketing/Phase IV)
Pfizer (PFE)'s Lung Cancer Drug Xalkori Effective In Rare Gene Trial 9/29/2014 6:08:54 AM
Genentech (RHHBY)'s New Breast Cancer Drug Greatly Extends Survival Rates 9/29/2014 6:22:40 AM
Synapse Biomedical Announces The Early Completion Of Enrollment In The FDA Post Approval Study For ALS Patients 9/30/2014 7:47:40 AM
Janssen Pharmaceutical Inc. Release: ZYTIGA®* Plus Prednisone Demonstrates Statistically Significant Overall Survival In Men With Advanced Prostate Cancer Prior To Chemotherapy 9/29/2014 9:05:14 AM
Daiichi Sankyo, Inc. (4568.t) Receives Approval For Additional Indications Of LIXIANA® (Edoxaban) In Japan 9/26/2014 8:30:52 AM
Repros Therapeutics Inc. (RPRX) Release: Androxal® Second Pivotal Study Achieves Superiority In Top Line Analysis For Both Co-Primary Endpoints Versus Marketed Topical Gel In The Treatment Of Secondary Hypogonadism 9/26/2014 7:16:45 AM
EPIRUS Biopharmaceuticals Announces Positive 58 Week Follow Up Data For BOW015 For Treatment Of Rheumatoid Arthritis 9/23/2014 10:40:47 AM
Parenteral Drug Association Launches Effort To Harmonize Global Post-Approval Changes Protocols 9/22/2014 7:56:58 AM
Zogenix, Inc. (ZGNX) Release: New Data Shows Zohydro® ER Reduced Pain And Improved Function In People With Chronic Pain 9/18/2014 11:17:51 AM
Janssen-Cilag International NV (JNJ) Release: Results From Head-To-Head Studies Of INVOKANA® (Canagliflozin) Versus JANUVIA (Sitagliptin) Highlight The Importance Of Weight-Change On Quality Of Life And Cost Effectiveness Of Canagliflozin Among People With Type 2 Diabetes 9/17/2014 11:21:55 AM
Vince & Associates Clinical Research Completes Enrollment Of Human Abuse Liability Study For Centanafadine For Adult ADHD 9/16/2014 12:28:26 PM
Study Shows Novo Nordisk A/S (NVO)'s New Diabetes Drug Tresiba Effective And Safe For Children 9/16/2014 6:05:24 AM
Astellas Pharma Inc. (ALPMY) Release: U.S. FDA Approves New Indication For The Use Of XTANDI® (enzalutamide) Capsules For Patients With Metastatic Castration-Resistant Prostate Cancer 9/11/2014 7:16:16 AM
Teva Pharmaceutical Industries Limited (TEVA) Presents New Data Which Demonstrate Reduction Of Injection-Related Adverse Events With The Less Frequent Dosing Of Three-Times-A-Week COPAXONE® (Glatiramer Acetate Injection) 40 Mg Compared To Daily COPAXONE® 20 Mg 9/11/2014 7:59:33 AM
Novartis AG (NVS): Rate Of Brain Shrinkage Faster In Multiple Schlerosis Patients 9/10/2014 6:50:49 AM
1234567
//-->